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Abstract
Introduction: This study aimed to explore the barriers and facilitators to implementing early therapeutic electrical stimulation (ES)
treatment from both the patient and therapist perspectives as part of a feasibility study.
Methods:
Design: Interviews were conducted with patients and their carers and focus groups with the therapists post-intervention period.
Setting: Interviews were in the patient’s homes and for the focus groups in a specialist stroke unit in Nottinghamshire.
Subjects: Fifteen patient participants (34% of sample) were interviewed (intervention n = 9; control group n = 3; carers n = 3). Sixteen
therapists (9 occupational therapists; 7 physiotherapists) took part in the three focus groups.
Intervention: Participants were randomized to receive usual care or usual care and ES to wrist flexors and extensors for 30 min, twice
a day, 5 days a week for 3 months.
Findings: The barriers to ES treatment cited by the therapists outweighed the barriers mentioned by patients. Therapists’ barriers
included lack of confidence and staff knowledge regarding ES and time pressures of delivering the ES. No patients mentioned time as
a barrier and considered the treatment regime to be acceptable; however, lack of staff support was mentioned 14 times by them.
Conclusion: Although initially the perceived barrier for therapists was time restrictions, after analysing the data, it appears that
confidence/knowledge is the real barrier, and time is the manifestation of this underlying self-doubt. Patients were able to confidently
self-manage treatment, and although efficacy was not measured, patients volunteered information regarding its perceived benefit,
and no adverse effects were reported.
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Introduction
Post-stroke upper limb complications
Stroke continues to be a global leading cause of adult dis-
ability (National Audit Office, 2010). Around 70–80% of
stroke survivors are affected by upper limb hemiparesis
which is a chronic and disabling problem for an estimated
40% (Royal College of Physicians, 2012). In the presence of
persistent paresis, arm muscles atrophy rapidly, and patients,
particularly those with spasticity and pain, are at an increased
risk of developing painful muscle contractures (fixed joint
deformities) (Malhotra et al., 2011). Contractures have 6-
month incidence rates of 22% (elbow and forearm) and 13%
for wrist and hand (Kwah et al., 2012) and can become
established as early as 6 weeks after stroke (Malhotra et al.,
2011). One possible cause for contracture is the lack of
adequate upper limb therapy input (Intercollegiate Stroke
Working Party, 2012, 2016; National Institute for Clinical
Excellence, 2013). In England, patients do not always receive
the recommended 45 min per day therapy (Intercollegiate
Stroke Working Party, 2012). Kaur et al. (2012) found that on
average, patients on stroke units receive between 0.9 and
7.9 min of upper limb therapy. Therefore, there is a need to
increase the amount of therapy targeted specifically at the arm
and hand in a cost- and resource-effective manner. One way is
to use technology and encourage self-management of treat-
ment by patients and their informal carers. Furthermore,
empowerment via self-management has significant positive
effects on functional recovery (Sit et al., 2016).
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Surface neuromuscular electrical stimulation (ES) is an
inexpensive technology that has been developed to stimulate
a muscle contraction and provide rehabilitative therapy. For
those patients unlikely to make functional gains, prevention
of complications such as pain and contractures should be the
focus of therapeutic interventions, and there is some evidence
that treatment with ES is of potential value (Dimitrijević and
Soroker, 1994; Malhotra et al., 2013; Pandyan et al., 1997;
Rosewilliam et al., 2012).
Previous pilot trials of ES have only focussed on stim-
ulation of the extensor muscles and have not stimulated the
flexor muscle group but have demonstrated some benefits in
terms of slowing the rate of deterioration, and in some cases,
facilitating recovery; however, effect sizes were small
(Malhotra et al., 2013; Pandyan et al., 1997; Rosewilliam
et al., 2012). These studies concluded that the treatment was
not given for long enough, and premature discontinuation of
therapy may have reduced any potential therapeutic effect.
However, the muscles at risk of shortening are the wrist and
forearm flexors, and the most effective method of loading
the soft tissue structures of the flexors in patients who are
unable to fully activate their muscles is by electrically
stimulating these muscles. Furthermore, evidence suggests
that early initiation (24 h post-stroke) of rehabilitation in-
terventions and high intensity of treatment can enhance the
chances of neurological recovery (Bernhardt et al., 2013,
2017; Biernaskie et al., 2004; Kwakkel et al., 2003, 2006).
Previous studies do not recruit or prescribe ES early after
stroke, for example, an underpowered trial found no effect
from ES; however, they recruited up to 6 months post-stroke
(Wilson et al., 2016). This is borne out in meta-analyses
which ascertained that ES significantly improved Activities
of Daily Living when initiated within 2 months; however,
this effect disappeared when initiated by 6 months (Eraifej
et al., 2017).
The early electrical stimulation to prevent
complications in the arm post-stroke study
Early electrical stimulation to prevent complications in the arm
post-stroke (ESCAPS) evaluated the feasibility of delivering
a definitive randomized controlled trial of usual care versus
usual care and early ES therapy to the wrist extensor and wrist
flexor muscles to prevent the post-stroke complications of pain
and contractures in the arm (Fletcher-Smith et al., 2016). The
full protocol and methods are reported elsewhere (Fletcher-
Smith et al., 2016, 2019), but briefly ESCAPS recruited 40
patients admitted to one stroke unit in England within 72 h post-
stroke. They were randomized 1:1 to receive either the in-
tervention, that is, ES,1 for 30 min, twice a day, Monday to
Friday for 3 months in conjunction with usual care, or the
control group of usual care. Participants randomized to the
control group did not receive ES therapy but received all usual
care which included all the therapy interventions that are
standard practice as per national clinical guidelines
(Intercollegiate Stroke Working Party, 2016). It was not
possible to collect data on the nature or volume of usual care.
Intervention participants were provided with a device, so they
could continue when discharged.
Participants on the trial were assessed on a series of
outcome measures at baseline (prior to randomization),
3 months (immediately following the 3-month intervention
phase), 6 months and 12 months. The publication of the
quantitative outcomes is published elsewhere (Fletcher-Smith
et al., 2019); here, we report the findings of the supplementary
qualitative study which explored the barriers and facilitators
to implementing early therapeutic ES treatment from both the
patient and therapist perspectives. Patient, carer and thera-
pists’ opinions were sought on both treatment acceptability
and aspects of the trial design for the purpose of informing
protocol development for a subsequent definitive trial.
Methods
Ethical approval [REC reference: 15/EM/0006] was granted
for a sample of patients/carers (n = 12) and therapists (n = 16)
involved in the ESCAPS feasibility RCT to be recruited to the
qualitative study.
Patient and carer interviews
The information sheet provided to the participants prior to
recruitment to the feasibility study stated that they may be
invited to participate in the interviews. A representative sample
based on age, sex and baseline National Institutes of Health
Stroke Scale scores of participants was recruited for the in-
terviews. Participants who had completed their final follow-up
assessment andwhowould be able to communicate freelywere
invited. After giving informed written consent, participants and
their informal carers were interviewed in their own homes by
Kate Allatt (KA) and JFS. The patients all knew JFS as she had
carried out all of the follow-up assessments and most of the
baseline assessments. Kate Allatt was not known to them prior
to the interview. Arguably, the prior relationship between JFS
and the participants may have biased the data; however, the
questions were trial focussed rather than efficacy, and upon
analyses, there were no qualitative differences between the data
obtained between the two interviewers.
Interviews lasted between 30 and 60 min and were audio
recorded and transcribed verbatim. The researcher followed an
ethically approved semi-structured interview guide. Intervention
participants were asked questions on the following topics:
1. How they would describe the ES treatment.
2. Their experience of the first treatment session.
3. Their views on the early application (within 72 h
post-stroke) of ES treatment.
4. The sensation of the treatment.
5. The perceived effect of the treatment.
6. The prescribed wearing schedule of the device (frequency
of treatments, duration and dose).
7. Their ability to use the device independently.
8. Any problems experienced in using the device.
9. Their experience of being involved in the clinical trial.
1The NeuroTrac Rehab Verity Medical Limited in compliance with the European Union
Medical Device Directive MDD93/42/EEC under the supervision of SGS, notified body number
0120 CE mark status. Verity Medical Ltd. is certified by SGS to the following quality standards:
ISO 9001:2008, ISO13485:2003.
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Furthermore, participants from the control group were
interviewed and asked about their experience of being in-
volved in a trial where they were randomized to usual care.
Therapist focus groups
All of the National Health Service (NHS) therapists (phys-
iotherapists and occupational therapists) who had been in-
volved in supporting the delivery of the ES treatment as part
of the ESCAPS trial were invited to participate in a focus
group. Three focus groups were held during the in-
tervention phase. Each was held in a meeting room on the
hospital grounds and lasted 1 h. Two researchers who were
known to the therapists (JFS and KA) led the focus groups.
Once again bias was minimized as the questions, guided by
an ethically approved topic guide, were trial focussed
rather than perceptions of efficacy.
Focus group participants were asked to discuss the fol-
lowing topics:
1. Views on the patient inclusion/exclusion criteria for the
ESCAPS study.
2. Assessments used in the study.
3. Their experience of administering the ES treatment.
4. Experience of training patients and carers to apply the
treatment.
5. Factors that might facilitate implementation of this type of
intervention in clinical practice.
6. Possible barriers that might affect implementation of the
intervention.
7. Experience of delivering ES as part of a randomized
controlled trial.
The focus groups were audio recorded and transcribed
verbatim.
Analyses
After verbatim transcription, the transcripts were read
a number of times by two researchers JFS and DMW after
checking the transcripts whilst listening to the audiotapes to
ensure that they were accurate and to add any contextual or
reflective data. Framework analysis was used (Ritchie and
Spencer, 1994). After familiarization, both researchers in-
dependently began coding the data. After a few transcripts
were coded, the researchers met to compare the codes and
their groupings to agree on a set of codes going forward,
thereby developing an analytical framework. After the
framework had been determined, this was used for the
analyses of the following transcripts. Both researchers
worked together to chart the data from the transcripts onto the
framework matrix before initial interpretation. The frame-
work matrix and interpretation was then discussed in the trial
management meetings with the other collaborators including
an expert by experience.
Findings
Fifteen patient participants representing 34% of the sample
were interviewed including intervention (n = 9), control
group (n = 3) and carers (n = 3) involved in supporting the
treatment. Carer’s demographic data were not collected;
however, the demographic details of the patient participants
interviewed are included in Table 1.
Sixteen female therapists (9 occupational therapists and
7 physiotherapists), NHS bands 3–6 (occupational/
physiotherapist assistants n = 13) and band 7 (qualified
occupational/physiotherapists n = 2) to band 8 (clinical leads
n = 1) participated in the three therapist focus groups. These
bands which are underpinned by a Knowledge and Skills
Framework are designed to ensure equitable pay and oppor-
tunities for progression for all non-medical staff. The bands are
based on qualifications and years of experience. This sample
included staff who had been involved in establishing the
correct area for electrode placement and providing the initial
treatment (qualified band 5 and above staff) or in supporting
subsequent treatment sessions (band 3 and above).
The data from the patients, carers and the therapy staff
formed overarching themes related to the clinical application
of early ES therapy and issues related to the trial design and
delivery.
Confidence and knowledge
The barriers to ES treatment cited by the therapists out-
weighed the barriers mentioned by patients. Therapists’
barriers included lack of confidence and staff knowledge
(mentioned 29 times):
‘Probably us OTs are less comfortable with using
electrical stimulation than physios are because they
would use TENS gloves and things like that so we are
probably less comfortable with it and it would take a bit
more practice’ [Occupational Therapist, focus group 2].
‘You don’t know whether you’ve got it in the right place.
We’re shown how to do it and yes we know our
anatomy, or we get the book out and look at it, but you
just think, you just doubt yourself don’t you, or if you’re
doing it right or not?’ [Physiotherapist, focus group 3].
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‘It was difficult to get movement with this particular
patient that we had to go back to the text book and still
didn’t know very well’ [Occupational Therapist, focus
group 3].
Due to these issues, therapists wanted more training and
support and also suggested a troubleshoot list/list of fre-
quently asked questions would be useful.
Some of the confidence issues were due to pre-conceived
ideas about the importance of ‘normal movement’. Therapists
were concerned about the positioning of the arm and hand for
treatment (mentioned in two out of three focus group dis-
cussions) and were concerned with eliciting abnormal
movement as a result of the ES treatment:
‘There’s been times when there’s been multiple thera-
pists going in and trying to get the right and the perfect
position’ [Physiotherapist, focus group 3].
‘I don’t want to be feeding the wrong pattern of movement
for 30minutes twice a day’ [Physiotherapist, focus group3].
‘I think there will be confidence issues and you know, is
this working?Am I doing this in the right way? And if you
don’t get that visual kind of payback that it is working
and you’ve got the perfect wrist extension. I think we all
want the perfect movement and I know actually, the
project is you don’t have to have the perfect movement
but I think that we all kind of aim to achieve a nice wrist
extension that looks good and we don’t have a deviation.
A nice flexion that looks good. And I guess that’s how we
are all taught, especially if it’s a band 5, it’s like normal
movement, normal movement, so that when we get non
normal movement we don’t like it very much’ [Physio-
therapist, focus group 3].
Comments also suggested a perceived complexity of the
intervention by therapy staff:
‘I don’t have enough experience with that equipment or
how it’s working because I don’t seem to ever be able to
do it right every time I try. I never seem to be able to get
it right’ [Occupational Therapist, focus group 3].
On the contrary, all patient participants who had been al-
located to the intervention arm of the trial reported being able to
confidently self-manage the ES treatment (mentioned 19 times):
‘Actually it wasn’t difficult, I mean I didn’t struggle with
it at all’ [Participant 1, female, aged 70].
‘I was quite happy to start straight away and I was able
to put the electrodes on myself and do it so I didn’t have
any problems there. Yes, I just got on with it…I just
carried on using it. It wasn’t difficult’ [Participant 2,
female, aged 67].
These opposing opinions could be due to dialectic model
of reasoning (Edwards and Jones, 2007). Underlying the
therapist’s approach is hypothetico-deductive reasoning
which underpins the biomedical model of health care (Elstein
et al., 2013). Therapists quantify, measure and grade what
they are seeing against their held ‘truth’ which is what they
expect. However, underlying the patient perspective is the
self-determination theory which is argued to underpin home
exercise regimen with the most adherent being those with
intrinsic motivation, for example, believing that completing
the treatment will benefit them (Deci and Ryan, 2000, 2010).
Although efficacy was not questioned during the interviews,
many patients volunteered this information and perceived the
ES to be of benefit (mentioned 27 times by 7 patients).
Time
Another barrier was the perceived time pressures that were
cited by therapists during the focus group discussions
(mentioned 11 times):
‘I reckon one of the biggest things would just be the time
factor. The feasibility of making sure it’s on twice a day
because on some days on any ward it’s just so busy that
it might just get missed’ [Physiotherapist, focus group 2].
‘If I might have ten new patients that day, I’ve not only
got to do the new patients but then I’ve got to do that as
well and don’t have that amount of time really’
[Physiotherapist, focus group 3].
‘Especially when it’s Friday afternoon and they want
them to go for the weekend, the last thing you’re going
to have time to do on Friday afternoon is teach the
family how to use electrical stimulation’ [Occupational
Therapist, focus group 3].
No patients mentioned time as a barrier and considered the
treatment regime to be acceptable (mentioned 17 times by 11
patients). However, lack of staff support was mentioned 14
times during the patient and carer interviews:
‘The therapists didn’t really show me how to use it
because I think they were in a mess themselves
sometimes, you know, but it was alright’ [Participant 4,
female patient aged 80].
‘The problem was I didn’t know how to put it on in the
hospital. Some nurses did. Then there were certain
people that we could if they were on that shift. We would
say, can you help me, but if they were busy they couldn’t
you see. It was whether they were busy or not. On the
stroke ward I think sometimes if they hadn’t got the staff
or if they were busy it got overlooked you know’
[Participant 6, female patient aged 66].
In terms of the timing of the early intervention, it was
viewed as a barrier by therapists (mentioned during two focus
groups) because of the pressure it placed on staff but was
considered acceptable to patients (12 mentions during eight
of the patient interviews).
Discussion
The data demonstrated a discord between the perceptions of the
clinicians and the patients, with both overarching themes of
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confidence and knowledge, and time being perceived as
a barrier by clinicians, whilst the patients did not perceive them
as barriers. Confidence/knowledge was the main barrier per-
ceived by clinicians, and time appeared to be a manifestation of
this underlying self-doubt. Patients however argued that they
were able to confidently self-manage treatment. They also ar-
gued that the treatment regimen was acceptable. However, they
did report lack of staff support which arguably could be due to
either time pressures or confidence and knowledge of staff.
These themes resonate with previous research. One
qualitative study looked at the perspectives regarding as-
sistive technologies for the treatment of stroke in patients,
caregivers and health professionals. They found that patients
were keen to self-manage and argued that if they were taught
how to use the devices in hospital, they would be happy to
continue at home. However, once again the health pro-
fessionals (all but one being physiotherapists or occupational
therapists) were more ambivalent about using assistive
technologies, citing the time required to prescribe and teach
people how to use them, as well as preparing, setting up and
maintaining the assistive technologies as an issue (Demain
et al., 2013). Patients in Demain et al.’s study noted that
therapists were overworked which echo the participant’s
perspectives in the current study.
Another study which collected data from 298 physi-
otherapists regarding using functional ES found that time
was mentioned as a barrier to usage more often than any
other resource. Therapists reported short treatment sessions
and lengths of stay, large caseloads and the time required to
set up the units and change their parameters as barriers
(Auchstaetter et al., 2016). Underpinning this is that
healthcare models have been developed by service pro-
viders, who prioritize different outcomes from patients
(Hammel et al., 2013; Ripat and Booth, 2005), which results
in a bias towards independence and safety, rather than
changes in factors which are meaningful to patients such as
quality of life (Steel, et al., 2016).
Knowledge has also been argued as a barrier to using
assistive technologies by earlier research. Demain et al.
(2013) found that health professionals were concerned
about a lack of efficacy research and were worried about the
potential risk of harm. Lack of knowledge was also reported
by their patient participants who argued that their therapists
perhaps lacked the knowledge about technologies. Demain
and team found that therapists were extremely risk adverse,
whereas the patients and carers were more willing to accept
risks. This is supported by a more recent study (Auchstaetter
et al., 2016). Correlations were found between using func-
tional ES and knowledge of the evidence (r = 0.279, p <
0.001) and education in its use (r = 0.15, p = 0.013).
Therapists acknowledged the importance of hands-on ex-
perience and ultimately report that a facilitator for using
functional ES was the therapist feeling comfortable and
confident in applying it. These differences in perspectives
between patients and therapists limit the effectiveness of
patient-centred approaches (Steel et al., 2016).
The findings from the patient and carer interviews and the
therapist focus groups informed a number of improvements
to the ongoing feasibility study and the protocol for the
subsequent definitive trial. For example, in addition to the
therapist training workshops, a number of staff drop-in
sessions were provided for the nursing staff on the stroke
unit to provide them with a clear and simple explanation of
the purpose of the ESCAPS study, the aims of the ES
treatment, and how to apply the treatment, remove the
electrode pads from the skin and correctly store the electrodes
when not in use. Therapists were also encouraged to attend
any of these drop-in sessions for further refresher training if
required. Although efficacy was not measured, patients
volunteered information regarding their perceived benefit,
and no adverse effects were reported.
Conclusion
This qualitative work will inform the design of a definitive
trial. Ultimately, ES may provide a cost-effective solution to
achieving recommended therapeutic targets which may result
in real patient benefit.
Key Points for Occupational Therapy
1. A clinical trial in early ES for stoke-affected upper limbs
is feasible.
2. Therapists’ barriers included lack of knowledge regarding
ES and time pressures of delivering the ES.
3. Patients considered the treatment regime to be acceptable;
however, lack of staff support was mentioned.
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